In ER status‐stratified analyses, there was evidence for an association of HGF with ER− breast cancer risk [odds ratio (OR) per standard deviation (SD) increase: 1.17, 95% confidence interval (CI): 1.01–1.35; p = 0.035]. This evidence concerns the gene HGF and breast carcinoma.